Neoadjuvant Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early TNBC: Surgical Outcomes from the Phase 3 KEYNOTE-522 Study

Kummel, S ; Schmid, P ; Harbeck, N ; Takahashi, M ; Untch, M ; Boileau, JF ; Cortes, J ; McArthur, H ; Dent, R ; O'Shaughnessy, J ; Pusztai, L ; Foukakis, T ; Park, YH ; Hui, RN ; Cardoso, F ; Denkert, C ; Zhu, YL ; Pan, W ; Karantza, V ; Fasching, PA

ANNALS OF SURGICAL ONCOLOGY, 2023, Vol.30 (SUPPL 2), p.S295 [Periódico revisado por pares]

Texto completo disponível